信高敏 HBsAg 检测阳性与非 HBV 相关 HCC 患者较差的预后显著相关--作者的回复

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-10-12 DOI:10.1111/apt.18340
Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Naoya Sakamoto
{"title":"信高敏 HBsAg 检测阳性与非 HBV 相关 HCC 患者较差的预后显著相关--作者的回复","authors":"Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Naoya Sakamoto","doi":"10.1111/apt.18340","DOIUrl":null,"url":null,"abstract":"LINKED CONTENTThis article is linked to Yasuura et al papers. To view these articles, visit <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://doi.org/10.1111/apt.18229\">https://doi.org/10.1111/apt.18229</jats:ext-link> and <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://doi.org/10.1111/apt.18300\">https://doi.org/10.1111/apt.18300</jats:ext-link>.","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"11 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Letter: A Positive High‐Sensitivity HBsAg Test Was Significantly Associated With Poorer Prognosis in Patients With Non‐HBV‐Related HCC—Authors' Reply\",\"authors\":\"Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Naoya Sakamoto\",\"doi\":\"10.1111/apt.18340\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"LINKED CONTENTThis article is linked to Yasuura et al papers. To view these articles, visit <jats:ext-link xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\" xlink:href=\\\"https://doi.org/10.1111/apt.18229\\\">https://doi.org/10.1111/apt.18229</jats:ext-link> and <jats:ext-link xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\" xlink:href=\\\"https://doi.org/10.1111/apt.18300\\\">https://doi.org/10.1111/apt.18300</jats:ext-link>.\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2024-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/apt.18340\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.18340","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

链接内容本文与 Yasuura 等人的论文链接。要查看这些文章,请访问 https://doi.org/10.1111/apt.18229 和 https://doi.org/10.1111/apt.18300。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Letter: A Positive High‐Sensitivity HBsAg Test Was Significantly Associated With Poorer Prognosis in Patients With Non‐HBV‐Related HCC—Authors' Reply
LINKED CONTENTThis article is linked to Yasuura et al papers. To view these articles, visit https://doi.org/10.1111/apt.18229 and https://doi.org/10.1111/apt.18300.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease? Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply. Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly Approach. Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1